Marex Group’s uniQure QURE Stock Holding History

Marex Group’s Portfolio QURE Stock Details QURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$327K	Buy	+20,000	New	+$405K	﹤0.01%	745

Other funds holding QURE

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Marex Group's QURE Position: Q1 2026 in Review

Marex Group reduced its uniQure (QURE) stake by 7% in Q1 2026, selling an estimated $121K and leaving 80,013 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #388.

Marex Group first reported a position in QURE in Q4 2023 and has held it in 9 quarters since. The position peaked at $5.07M in Q3 2025. 212 funds tracked by Wall St. Rank hold QURE as of Q1 2026.

Marex Group held 80,013 shares of uniQure worth $1.31M as of Q1 2026.
Marex Group sold 5,980 uniQure shares in Q1 2026, an estimated $121K.
uniQure made up 0.01% of Marex Group's portfolio in Q1 2026, its #388 holding.
Marex Group first reported a position in uniQure in Q4 2023 and has held it in 9 quarters since.
Marex Group's uniQure position peaked at $5.07M in Q3 2025.
212 funds tracked by Wall St. Rank held uniQure as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.